Development of Masitinib Derivatives with Enhanced M^pro Ligand Efficiency and Reduced Cytotoxicity by Cintia A. Menendez, Adil Mohamed, Gustavo R. Perez-Lemus, Adam M. Weiss, Benjamin W. Rawe, Guancen Liu, Alex E. Crolais, Emma Kenna, Fabian Byléhn, Walter Alvarado, Dan Mendels, Stuart J. Rowan, Savaş Tay, Juan J. de Pablo

Get full text